Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19

NCT04789603 | Unknown DMC

• 1 other identifier: CBAS-2020-03
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 2

Brief Summary

Since the beginning of the pandemic caused by SARC-CoV 2, more than 81 million cases have been diagnosed and caused around 1,7 million deaths. Currently, a drug is being sought for the treatment of coronavirus. The worldwide effort to create an effective and safe COVID-19 vaccine is beginning to yield results. Several vaccines now have been authorized around the globe; many more remain in development. Nonetheless, in the absence of effective pharmacological treatment and given the virus's transmission capacity, different alternatives have been proposed to stop the transmission of the virus. Therefore, these preventive measures against transmission are expected to remain in force for some time. The transmission of the virus occurs from person-to-person; different studies conclude that transmission occurs by aerosols from respiratory droplets. The optimal distance between people to stop person-to-person transmission is uncertain. For this reason and given that there is no effective drug, transmission prevention is of great importance especially for pandemic mitigation in community settings. The World Health Organization (WHO) established simple precautions to prevent the spread of the virus such as physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning your hands, and coughing into a bent elbow or tissue. For this reason, the use of the mask has been proposed in several countries, being mandatory in many of them, for use in the health environment and daily use. The WHO recommends different types of masks depending on the person, where it will be used, or the population incidence in the area. Wearing a medical /surgical mask is recommended for people over 60, those who have underlying medical conditions, feel unwell, and/or look after an ill family member. For health workers, respirator masks (such as FFP2, FFP3, N95, N99) should be used in settings where procedures are generating aerosols. The use of a mask could imply an inspiratory and expiratory restraint and generate a feeling of discomfort in many people. It is responsible for an increase in the inspiratory and expiratory pressures generated. This feeling of discomfort and the increment of pressures causes shallow and forced breathing and increases the respiratory accessory musculature activation. Person et al. observed that the subjects who used a mask felt dyspnea clinically and significantly higher than those who did not use it. However, to our knowledge, no study has analyzed the parameters of physical effort, respiratory parameters, self-perceived dyspnea, and muscle activation using different types of masks in healthy subjects. For this reason, the present study hypothesis is that there are no changes between wearing and not-wearing a mask (surgical or N-95) in the effort and ventilatory parameters, even though there may be an increase in the tone of the cervical muscles or the perception of dyspnea using a face mask. This study aims to observe the effect that the surgical mask and the N-95 mask have in the distance walked, in the oxygenometry, in the heart rate, in the sensation of dyspnea, and the tone of the inspiratory accessory muscles during the 6 minutes walking test. Procedure After verifying that the subjects meet the inclusion criteria and sign the consent, they will be given a registration number. An investigator will observe the number in a random list and included the participant in one of the three groups (without a mask, with a surgical mask, and with N95 mask). This researcher will make an initial registration of demographic data (gender, age, weight, height, cardiorespiratory pathology, smoker, number of cigarettes per day, a sport performed, hours of daily sport, and days of sport per week). Before the test, all the subjects will have to remain for 30 minutes without a mask, breathing normally. This phase will be called the resting phase. Subsequently, the subjects will go to the area where the 6MWT will be carried out. Each one of them will be performed the test according to the group to which they will be assigned. An investigator, blinded to the subsequent assessment, will encourage the participants to take the 6MWT according to the recommendations mentioned above. After performing the 6MWT, all subjects will go to the assessment area. All the subjects will wear a surgical mask so that the researcher can not know to which group they have been assigned. Besides, this researcher will not have access to the registration number or the 6-minute walking test area. At the end of each resting phase, SpO2 and baseline HR will be recorded. After every 6MWT, the HR, SpO2, and self-perceived dyspnea will be recorded. The muscle tone will also be assessed with the MyotonPRO in middle scalene and SCM. Subjects will have the option of retaking the test, going through all the phases mentioned above.

Conditions

Pulmonary Disease; Covid19; Physical Disability

Keywords

covid-19; muscle tone; mask

Outcome Measures

Primary Outcomes (1)

• 6 minutes walk test (minutes)

  The volunteers had to walk as fast as possible without running for 6 minutes. Each minute, the subjects will be encouraged to continue at the same pace and not stop

  Change between baseline (immediately before intervention) and post intervention (immediately after intervention)

Secondary Outcomes (6)

• Dyspnea using the visual analogue scale (VAS) (cms)

  Change between baseline(immediately before intervention) and post intervention (immediately after intervention)

• Heart Rate (b/min)

  Change between baseline(immediately before intervention) and post intervention (immediately after intervention)

• Transcutaneous oxygen saturation (% of saturation)

  Change between baseline(immediately before intervention) and post intervention (immediately after intervention)

• Frequency Muscle tone with MyotonePRO device (Hz)

  Change between baseline and post intervention (1 month), after 3 months and after 6 months

• Dynamic Stiffness Muscle tone with MyotonePRO device (N/m)

  Change between baseline and post intervention (1 month), after 3 months and after 6 months

Study Arms (3)

Without Mask Group

ACTIVE COMPARATOR

Patients who will perform the 6-min walk test without mask

Other: 6-min-walk without mask

Surgical Mask

ACTIVE COMPARATOR

Patients who will perform the 6-min walk test with surgical mask

Other: 6-min-walk surgical mask

Fpp2 Mask

EXPERIMENTAL

Patients who will perform the 6-min walk test with Fpp2 mask

Other: 6-min-walk Fpp2

Interventions

6-min-walk surgical mask OTHER

To walk as fast as possible without running for 6 minutes with surgical mask

Surgical Mask

6-min-walk Fpp2 OTHER

To walk as fast as possible without running for 6 minutes with Fpp2 mask

Fpp2 Mask

6-min-walk without mask OTHER

To walk as fast as possible without running for 6 minutes without mask

Without Mask Group

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age\> 18 years
• Being able to perform the 6 min-walk-test-

You may not qualify if:

• Cardiac-respiratory diseases
• Red flags.

Sponsors & Collaborators

• Universitat Internacional de Catalunya: lead

Study Sites (2)

Universitat Internacional de Catalunya

Sant Cugat del Vallès, Barcelona, 08195, Spain

COMPLETED

Universitat Internacional de Catalunya

Sant Cugat del Vallès, Spain

RECRUITING

MeSH Terms

Conditions

Lung Diseases; COVID-19

Interventions

Walking; Masks

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections

Intervention Hierarchy (Ancestors)

Locomotion; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena; Exercise; Motor Activity; Surgical Attire; Equipment and Supplies, Hospital; Equipment and Supplies; Protective Devices; Personal Protective Equipment; Surgical Equipment; Manufactured Materials; Technology, Industry, and Agriculture

Study Officials

• Albert Pérez-Bellmunt, PhD

  Universitat Internacional de Catalunya

  STUDY DIRECTOR

Central Study Contacts

Jacobo Rodríguez-Sanz, PhD

CONTACT

+34636136789; jrodriguezs@uic.es

Carlos López-de-Celis, PhD

CONTACT

+34606806767; carlesldc@uic.es

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: For randomization a computer software (www.random.org) will be used.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 4, 2021
• First Posted: March 9, 2021
• Study Start: May 10, 2021
• Primary Completion: June 1, 2021
• Study Completion: June 1, 2021
• Last Updated: May 11, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

ES (2)